Antibody Contract Manufacturing Market Report 2023 – Market Size, Growth Rate, Major Drivers And Key Trends

The Business Research Company’s Antibody Contract Manufacturing Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Antibody Contract Manufacturing Global Market Report 2023 evaluates antibody contract manufacturing market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12665&type=smp

The global antibody contract manufacturing market is expected to grow from $11.18 billion in 2022 to $12.84 billion in 2023 at a compound annual growth rate (CAGR) of 14.82%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The antibody contract manufacturing market is expected to reach $21.79 billion in 2027 at a CAGR of 14.13%.

The rising number of clinical trials is expected to propel the growth of the antibody contract manufacturing market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. The number of clinical trials involving antibody-based therapeutics or diagnostics expands, for high-quality antibodies, ensuring a timely and compliant supply for clinical trials. For instance, in May 2023, according to ClinicalTrials.gov, a part of the National Institutes of Health (NIH), a US-based government agency responsible for conducting and supporting medical research, in all 50 states of the United States and 221 countries, the number of registered clinical trials studies climbed from 399,499 in 2022 to 437,533 in 2023. Additionally, around 241,498 studies, or 53% of the total, were registered outside the United States, compared to 140,492 studies (31%) registered just in the United States. Therefore, the rising number of clinical trials is driving the growth of the antibody contract manufacturing market.

Get More Information On The Antibody Contract Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/report/antibody-contract-manufacturing-global-market-report

The antibody contract manufacturing market segments in the report are:

1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products

2) By Source: Mammalian, Microbial

3) Scale Of Operation: Preclinical, Clinical, Commercial

4) By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users

The table of contents in TBRC’s antibody contract manufacturing market report includes:

  1. Executive Summary
  2. Antibody Contract Manufacturing Market Characteristics
  3. Antibody Contract Manufacturing Market Trends And Strategies
  4. Antibody Contract Manufacturing Market – Macro Economic Scenario
  5. Global Antibody Contract Manufacturing Market Drivers and Restraints

.

  1. Global Antibody Contract Manufacturing Market Competitive Benchmarking
  2. Global Antibody Contract Manufacturing Market Competitive Dashboard
  3. Key Mergers And Acquisitions In The Antibody Contract Manufacturing Market
  4. Antibody Contract Manufacturing Market Future Outlook and Potential Analysis
  5. Appendix

Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model